Opexa Therapeutics Company Profile (NASDAQ:OPXA)

About Opexa Therapeutics

Opexa Therapeutics logoOpexa Therapeutics, Inc. (Opexa) is a biopharmaceutical company. The Company is engaged in the development of a personalized immunotherapy with the potential to treat various illnesses, including multiple sclerosis (MS), as well as other autoimmune diseases, such as neuromyelitis optica (NMO). These therapies are based on its T-cell technology. The Company's product candidates include Tcelna and OPX-212. Tcelna is an autologous T-cell immunotherapy that is being developed for the treatment of secondary progressive MS (SPMS) and is tailored to each patient's immune response profile to myelin. Tcelna is designed to reduce the number and/or functional activity of specific subsets of myelin-reactive T-cells (MRTCs) known to attack myelin. Tcelna is manufactured using its method for the production of an autologous T-cell product. In addition to the ongoing clinical development of Tcelna, the Company is developing OPX-212 as an autologous T-cell immunotherapy for the treatment of NMO.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: OPXA
  • CUSIP:
Key Metrics:
  • Previous Close: $3.27
  • 50 Day Moving Average: $4.06
  • 200 Day Moving Average: $3.29
  • 52-Week Range: $1.69 - $5.10
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.99
  • P/E Growth: 0.00
  • Market Cap: $23.05M
  • Outstanding Shares: 7,049,000
  • Beta: 1.39
  • Net Margins: -324.97%
  • Return on Equity: -109.48%
  • Return on Assets: -71.85%
  • Current Ratio: 2.34%
  • Quick Ratio: 2.34%
Additional Links:
Companies Related to Opexa Therapeutics:

Analyst Ratings

Consensus Ratings for Opexa Therapeutics (NASDAQ:OPXA) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.67 (256.78% upside)

Analysts' Ratings History for Opexa Therapeutics (NASDAQ:OPXA)
DateFirmActionRatingPrice TargetDetails
9/20/2016Maxim GroupSet Price TargetBuy$18.00View Rating Details
8/15/2016AegisReiterated RatingBuy$11.00View Rating Details
8/14/2016Chardan CapitalReiterated RatingBuy$6.00View Rating Details
(Data available from 9/24/2014 forward)


Earnings History for Opexa Therapeutics (NASDAQ:OPXA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/11/2016Q216($0.23)($0.30)ViewListenView Earnings Details
5/12/2016Q116($0.35)($0.31)ViewListenView Earnings Details
3/15/2016Q415($0.50)($2.05)ViewListenView Earnings Details
11/10/2015Q315($2.48)($0.42)ViewN/AView Earnings Details
8/12/2015Q215($0.08)($0.07)ViewListenView Earnings Details
5/12/2015Q1($0.15)($0.12)ViewListenView Earnings Details
2/23/2015($0.14)($0.12)ViewN/AView Earnings Details
8/14/2014Q214($0.13)($0.15)ViewN/AView Earnings Details
5/14/2014Q114($0.13)($0.13)$0.22 million$0.35 millionViewN/AView Earnings Details
8/14/2013Q213($0.37)$0.35 millionViewN/AView Earnings Details
11/14/2012Q312($0.10)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Opexa Therapeutics (NASDAQ:OPXA)
Current Year EPS Consensus Estimate: $-1.13 EPS
Next Year EPS Consensus Estimate: $-0.82 EPS


Dividend History for Opexa Therapeutics (NASDAQ:OPXA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Opexa Therapeutics (NASDAQ:OPXA)
Insider Ownership Percentage: 6.88%
Institutional Ownership Percentage: 6.40%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/17/2014Timothy C BarabeDirectorBuy10,000$1.15$11,500.00View SEC Filing  
9/16/2014Neil K WarmaCEOBuy10,000$1.11$11,100.00View SEC Filing  
12/18/2013Karthik RadhakrishnanCFOBuy8,000$1.70$13,600.00View SEC Filing  
12/18/2013Scott B SeamanDirectorBuy30,000$1.70$51,000.00View SEC Filing  
8/8/2013Karthik RadhakrishnanCFOBuy50,000$1.50$75,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Opexa Therapeutics (NASDAQ:OPXA)
News IconOpexa Therapeutics, Inc.'s (OPXA): Stock's Current Update - Hot Stocks Point (NASDAQ:OPXA)
www.hotstockspoint.com - September 23 at 6:07 PM
News IconOpexa Therapeutics Inc (NASDAQ:OPXA): Here's What Markets Have Missed - Street Register (NASDAQ:OPXA)
streetregister.com - September 18 at 10:51 AM
News IconOpexa Therapeutics Inc (NASDAQ:OPXA): Here’s What Markets Have Missed (NASDAQ:OPXA)
streetregister.com - September 16 at 10:07 AM
News IconStock Turning Lower in Trade: Opexa Therapeutics, Inc. (NASDAQ:OPXA) - Post News (NASDAQ:OPXA)
www.kentuckypostnews.com - September 15 at 10:05 AM
investing.com logoU.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.18% (NASDAQ:OPXA)
www.investing.com - September 14 at 6:44 PM
News IconNasdaq Index Only Major US Average to Close Positive, Helped by Apple (NASDAQ:OPXA)
www.economiccalendar.com - September 14 at 6:44 PM
biz.yahoo.com logoOPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:OPXA)
biz.yahoo.com - September 12 at 11:11 AM
finance.yahoo.com logoOpexa Therapeutics to Present at Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:OPXA)
finance.yahoo.com - September 7 at 10:10 AM
News IconShares Going Higher in Session: Opexa Therapeutics, Inc. (NASDAQ:OPXA) - Post News (NASDAQ:OPXA)
www.kentuckypostnews.com - August 24 at 9:45 AM
News IconWedbush analysts reiterate rating of Outperform on Opexa Therapeutics Inc. (NASDAQ: OPXA) - BNB Daily (blog) (NASDAQ:OPXA)
www.baseball-news-blog.com - August 15 at 8:51 AM
capitalcube.com logoETF’s with exposure to Opexa Therapeutics, Inc. : August 12, 2016 (NASDAQ:OPXA)
www.capitalcube.com - August 12 at 6:46 PM
News IconStocks Gainers/Losers Roundup: International Business Machines (NYSE:IBM), Opexa Therapeutics (OPXA), Opexa ... - Seneca Globe (NASDAQ:OPXA)
www.senecaglobe.com - August 12 at 9:52 AM
rttnews.com logoEARNINGS SUMMARY: Details of Opexa Therapeutics Inc. Q3 Earnings Report (NASDAQ:OPXA)
www.rttnews.com - August 11 at 7:09 PM
publicnow.com logoOpexa Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:OPXA)
www.publicnow.com - August 11 at 7:09 PM
biz.yahoo.com logoQ2 2016 Opexa Therapeutics Inc Earnings Release - After Market Close (NASDAQ:OPXA)
biz.yahoo.com - August 11 at 9:55 AM
publicnow.com logoOpexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Second Quarter 2016 Financial Results (NASDAQ:OPXA)
www.publicnow.com - August 9 at 9:51 AM
News IconHeightened Volatility Spotted on Shares of: Opexa Therapeutics, Inc. (NASDAQ:OPXA) - Engelwood Daily (NASDAQ:OPXA)
www.engelwooddaily.com - July 19 at 6:46 PM
News IconHow Many Opexa Therapeutics Inc (NASDAQ:OPXA)'s Analysts Are Bullish? - Consumer Eagle (NASDAQ:OPXA)
www.consumereagle.com - July 19 at 6:46 PM
capitalcube.com logoETF’s with exposure to Opexa Therapeutics, Inc. : July 19, 2016 (NASDAQ:OPXA)
www.capitalcube.com - July 19 at 12:57 PM
kcregister.com logoOpexa Therapeutics, Inc. (NASDAQ:OPXA) Went Up 2.34%: Bovie Medical (NYSEMKT:BVX), Anworth Mortgage Asset ... - KC Register (NASDAQ:OPXA)
www.kcregister.com - July 19 at 7:52 AM
News IconOpexa Therapeutics Incorporated (NASDAQ:OPXA) Sellers Covered 21.6% of Their Shorts - Press Telegraph (NASDAQ:OPXA)
presstelegraph.com - July 17 at 6:03 PM
ftsenews.co.uk logoNew Broker Ratings For Opexa Therapeutics, Inc. (OPXA) - FTSE News (NASDAQ:OPXA)
www.ftsenews.co.uk - July 15 at 11:40 AM
kcregister.com logoStocks to Watch: Opexa Therapeutics, Inc. (NASDAQ:OPXA), GlobeImmune Inc. (NASDAQ:GBIM), Westlake Chemical ... - KC Register (NASDAQ:OPXA)
www.kcregister.com - July 14 at 6:56 PM
News IconStock Volatility Focus for: Opexa Therapeutics, Inc. (NASDAQ:OPXA) - Engelwood Daily (NASDAQ:OPXA)
www.engelwooddaily.com - July 12 at 10:58 AM
fiscalstandard.com logoOpexa Therapeutics, Inc. (OPXA) Current Analyst Ratings - Fiscal Standard (NASDAQ:OPXA)
www.fiscalstandard.com - July 10 at 6:00 PM
News IconCan Opexa Therapeutics Inc's Tomorrow Be Different? The Stock Increases Again - Press Telegraph (NASDAQ:OPXA)
presstelegraph.com - July 7 at 6:42 PM
zacks.com logo5 Best-Performing Biotech Stocks of June (NASDAQ:OPXA)
www.zacks.com - July 5 at 6:27 PM
kcregister.com logoWorth Watching Stocks: Duke Energy Corporation (NYSE:DUK), Opexa Therapeutics, Inc. (NASDAQ:OPXA), Sapiens ... - KC Register (NASDAQ:OPXA)
www.kcregister.com - July 2 at 9:27 AM
News IconOpexa Therapeutics Incorporated (NASDAQ:OPXA) Shorts Decreased by 21.6% After Short Covering - Engelwood Daily (NASDAQ:OPXA)
www.engelwooddaily.com - July 2 at 9:27 AM
finance.yahoo.com logo5 Top Biotech Performers of 2016 (NASDAQ:OPXA)
finance.yahoo.com - July 1 at 5:19 PM
News IconHow Many Opexa Therapeutics Inc (NASDAQ:OPXA)'s Analysts Are Bearish? - Press Telegraph (NASDAQ:OPXA)
presstelegraph.com - June 28 at 6:37 PM
News IconCheck on Share Volatility: Opexa Therapeutics, Inc. (NASDAQ:OPXA) - Engelwood Daily (NASDAQ:OPXA)
www.engelwooddaily.com - June 28 at 6:37 PM
News IconShare Volatility Check for: Opexa Therapeutics, Inc. (NASDAQ:OPXA) - Press Telegraph (NASDAQ:OPXA)
presstelegraph.com - June 25 at 6:08 PM
ftsenews.co.uk logoOpexa Therapeutics, Inc. (OPXA) Updated Price Targets - FTSE News (NASDAQ:OPXA)
www.ftsenews.co.uk - June 25 at 6:08 PM
kcregister.com logoInvestors Are Watching: Globalstar Inc. (NYSEMKT:GSAT), Opexa Therapeutics (NASDAQ:OPXA), Advanced Micro ... - KC Register (NASDAQ:OPXA)
www.kcregister.com - June 21 at 11:03 AM
fiscalstandard.com logoOpexa Therapeutics, Inc. (OPXA) Analyst Price Targets For The Coming Week - Fiscal Standard (NASDAQ:OPXA)
www.fiscalstandard.com - June 20 at 8:16 AM
fxpips.com logoManufacturing Industry Top Gainers, Biggest Losers Summary (NASDAQ:OPXA)
www.fxpips.com - June 16 at 10:53 AM
News IconEarnings Analysis to Watch: Banco Santander (NYSE:BSBR), Opexa Therapeutics, Inc. (NASDAQ:OPXA) - Beacon Chronicle (NASDAQ:OPXA)
www.beaconchronicle.com - June 11 at 6:50 PM
investornewswire.com logoStrong Sell Calls Count For Opexa Therapeutics, Inc. (NASDAQ:OPXA) At 0 - Investor Newswire (NASDAQ:OPXA)
www.investornewswire.com - June 3 at 9:33 AM
News IconAnalyst Recommendations on These Stocks: Computer Sciences (CSC), Opexa Therapeutics (OPXA) - Beacon Chronicle (NASDAQ:OPXA)
www.beaconchronicle.com - May 28 at 2:27 PM
investing.com logoU.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.82% (NASDAQ:OPXA)
www.investing.com - May 26 at 2:31 PM
News IconVery Green Follow-Through Session (NASDAQ:OPXA)
www.fxstreet.com - May 26 at 2:31 PM
rttnews.com logoOpexa Therapeutics Inc. (OPXA) Has Surged To Nearly A 6-Month High (NASDAQ:OPXA)
www.rttnews.com - May 26 at 2:31 PM
thepointreview.com logoHealthcare Stocks to Lookout: Opexa Therapeutics Inc (NASDAQ:OPXA), Carbylan Therapeutics Inc (NASDAQ:CBYL ... - The Point Review (NASDAQ:OPXA)
www.thepointreview.com - May 25 at 2:34 PM
News IconNext Weeks Broker Price Targets For Opexa Therapeutics, Inc. (OPXA) - Share Trading News (NASDAQ:OPXA)
www.sharetrading.news - May 24 at 3:01 PM
tradecalls.org logoRevenue Update on Opexa Therapeutics Inc(NASDAQ:OPXA) - Trade Calls (NASDAQ:OPXA)
www.tradecalls.org - May 21 at 2:21 PM
biz.yahoo.com logoOPEXA THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:OPXA)
biz.yahoo.com - May 18 at 4:07 PM
kcregister.com logoMorning Alert: Comcast Corporation (NASDAQ:CMCSA), Opexa Therapeutics, Inc. (NASDAQ:OPXA), NuVasive, Inc ... - KC Register (NASDAQ:OPXA)
www.kcregister.com - May 18 at 3:03 PM
capitalcube.com logoOpexa Therapeutics, Inc. :OPXA-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:OPXA)
www.capitalcube.com - May 18 at 1:48 PM
News IconBroker Roundup For Opexa Therapeutics, Inc. (OPXA) - Share Trading News (NASDAQ:OPXA)
www.sharetrading.news - May 14 at 8:36 AM


Opexa Therapeutics (NASDAQ:OPXA) Chart for Saturday, September, 24, 2016

Last Updated on 9/24/2016 by MarketBeat.com Staff